Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sascha Gerdes

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Frontiers in Immunology|November 29, 2023
The gut microbiome in bullous pemphigoid: implications of the gut-skin axis for disease susceptibilityXiaolin Liu, Nina van Beek, Aleksa Cepic, et al.
Lancet (London, England)|September 21, 2025
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trialsLinda Stein Gold, April W Armstrong, Robert Bissonnette, et al.
The Journal of Allergy and Clinical Immunology|November 11, 2019
Protein-coding variants contribute to the risk of atopic dermatitis and skin-specific gene expressionSören Mucha, Hansjörg Baurecht, Natalija Novak, et al.
Nature Communications|November 17, 2021
Rare variant analysis in eczema identifies exonic variants in DUSP1, NOTCH4 and SLC9A4Sarah Grosche, Ingo Marenholz, Jorge Esparza-Gordillo, et al.
Nature Communications|February 28, 2025
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targetsNick Dand, Philip E Stuart, John Bowes, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targetsNick Dand, Philip E Stuart, John Bowes, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Frontiers in Immunology|November 29, 2023
The gut microbiome in bullous pemphigoid: implications of the gut-skin axis for disease susceptibilityXiaolin Liu, Nina van Beek, Aleksa Cepic, et al.
Lancet (London, England)|September 21, 2025
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trialsLinda Stein Gold, April W Armstrong, Robert Bissonnette, et al.
The Journal of Allergy and Clinical Immunology|November 11, 2019
Protein-coding variants contribute to the risk of atopic dermatitis and skin-specific gene expressionSören Mucha, Hansjörg Baurecht, Natalija Novak, et al.
Nature Communications|November 17, 2021
Rare variant analysis in eczema identifies exonic variants in DUSP1, NOTCH4 and SLC9A4Sarah Grosche, Ingo Marenholz, Jorge Esparza-Gordillo, et al.
Nature Communications|February 28, 2025
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targetsNick Dand, Philip E Stuart, John Bowes, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targetsNick Dand, Philip E Stuart, John Bowes, et al.
Pageof 11